Influence of Deleted in Colorectal Carcinoma Gene on Proliferation of Ovarian Cancer Cell Line SKOV-3 In Vivo and In Vitro

doi:10.1016/S1001-9294(11)60045-X

Abstract

Abstract: Objective To elucidate the effects of the deleted in colorectal carcinoma (DCC) gene on prolifera-tion of ovarian cancer cell line SKOV-3.
Method An exogenous recombinant eukaryotic expression vector pcDNA3.1(+)-DCC, containing human DCC cDNA coding sequences, was constructed and transfected into SKOV-3 cells (SKOV-3/DCC). The pcDNA3.1 (+) transfected cells (SKOV-3/Neo) and SKOV-3 cells were used as the positive and nega-tive controls, respectively. Expressions of DCC mRNA and protein were analyzed by RT-PCR and immuno-cytochemical analysis, respectively. Cell growth was detected by soft agar colony formation assay and MTT assay. Flow cytometry and transmission electron microscopy were used to assess the effects of DCC on cell cycle distribution and ultrastructure, respectively. BALB/c mice were used to evaluate the effects of DCC on tumorigenicity in vivo.
Results RT-PCR and immunocytochemical analysis revealed the exogenous DCC gene was suc-cessfully transfected into SKOV-3 cell lines and obtained permanent expression. The half maximal inhibitory concentration (IC50) of SKOV-3/DCC cells was significantly lower than that of SKOV-3 or SKOV-3/Neo cells (all P<0.05). DCC expression caused SKOV-3 cells to be arrested in G1 phase (78.0%), and electron microscopic analysis showed SKOV-3/DCC cells displayed typical morphological changes of apoptosis. Two mice xenografted with SKOV-3/DCC cells showed no tumor tumorigenecity. The tumor volume of BALB/c mice bearing SKOV-3/DCC cells (3.403 mm3) was smaller than that of SKOV-3 cells (9.206 mm3).
Conclusion DCC gene may play an important role in suppressing the growth of SKOV-3 cell line and inducing apoptosis.

Key words: ovarian cancer, deleted in colorectal carcinoma gene, gene therapy

Yan Cai, Chun-jie Hu, Jia Wang, Ze-hua Wang. Influence of Deleted in Colorectal Carcinoma Gene on Proliferation of Ovarian Cancer Cell Line SKOV-3 In Vivo and In Vitro[J].Chinese Medical Sciences Journal, 2011, 26(3): 175-181.

References 27

1.	Saegusa M, Machida D, Okayasu I, et al. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumor differentiation and progression. Br J Cancer 2000; 82:571-8. 2. Yao HP. Diagnosis and treatment of recurrent ovarian cancer. Zhonghua Fu Chan Ke Za Zhi 2003; 38:659-60.
3.	Carvalho AL, Chuang A, Jiang WW, et al. Deleted in co-lorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res 2006; 66: 9401-7.
4.	Li PL, Liu MM, Ni J. Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi 2003; 38:207-2.
5.	Yao D, He X, Yang RL, et al. Sonographic measurement of thyroid volumes in healthy chinese infants aged 0 to 12 months. J Ultrasound Med 2011; 30:895-8.
6.	Sato T, Satio H, Morita R, et al. Allelotype of human ovarian cancer. Cancer Res 1991; 51:5118-22.
7.	Cliby W, Ritland S, Hartmann L, et al. Human epithelial ovarian cancer allelotype. Cancer Res 1993; 53:2393-8.
8.	Brewster SF, Gingell JC, Browne S, et al. Loss of het-erozygosity on chromosome 18q is associated with mus-cle-invasive transitional cell carcinoma of the bladder. Br J Cancer 1994; 70: 697-700.
9.	Devilee P, van Vlietl M, Kuipers-Dijkshoorn N, et al. So-matic genetic changes on chromosome 18 in breast car-cinomas: is the DCC gene involved? Oncogene 1991; 6: 311-5.
10	Gao X, Honn KV, Grignon D, et al. Frequent loss of ex-pression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinoma. Cancer Res 1993; 55:2723-7.
11	Hoene MW, Halatsch M-E, Kabl GF, et al. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 1992; 52: 2616-9.
12	Miyake K, Inokuchi K, Dan K, et al. Alterations in the deleted in colorectal carcinoma gene in human primary leukemia. Blood 1993, 82: 3927-30.
13	Neuman WL, Wasylyshyn ML, Jacoby R, et al. Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes Chromosomes Cancer 1991; 3:468-73.
14	Scheck AC, Coons SW. Expression of the tumor sup-pressor gene DCC in human gliomas. Cancer Res 1993; 53: 5605-9.
15	Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247:49-56.
16	Mazelin L, Bernet A, Bonod-Bidaud C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 2004; 431:80-4.
17	Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 2004; 4:978-87.
18	Goi T, Yamaguchi A, Nakagawara G, et al. Reduced ex-pression of deleted colorectal carcinoma (DCC) protein in established colon cancer. Br J Cancer 1998; 77:466-71.
19	Enomoto T, Fujita M, Cheng C, et al. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer 1995; 71:462-7.
20	Kato H, Zhou Y, Asanoma K, et al. Suppressed tumori-genicity of human endometrial cancer cells by the restored expression of the DCC gene. Br J Cancer 2000; 82: 459-66.
21	Tanaka K, Oshimura M, Kikuchi R, et al. Suppression of tumorigenicity in human colon carcinoma cells by intro-duction of normal chromosome 5 or 18. Nature 1991; 349:340-2. 22. Velcich A, Corner G, Palumbo L, et al. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene. Oncogene 1999; 18:2599-606.
23	Fabre M, Martin M, Ulloa F, et al. In vitro analysis of the role of DCC in mucus-secreting intestinal differentiation. Int J Cancer 1999; 81:799-807.
24	Mehlen P, Rabizadeh S, Smipeas SJ, et al. The DCC gene product induces apoptosis by a mechanism requiring re-ceptor proteolysis. Nature 1998; 395:801-4.
25	Klingelhutz AJ, Hedrick L, Cho KR, et al. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 1995; 10:1581-6.
26	Forcet C, Ye X, Granger L, et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci U S A 2001; 98:3416-21.
27	Fazeli A, Dickinson SL, Hermiston ML, et al. Phenotype of mice lacking functional deleted in colorectal cancer (DCC) gene. Nature 1997; 386:796-804.

[1]	Dhakal Sweta, Zheng Yun-xi, Yi Xiao-fang. Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide [J]. Chinese Medical Sciences Journal, 2017, 32(3): 185-192.
[2]	Yong-qiang Yu, Huai-an Yang, Ming Xiao, Jing-wei Wang, Dong-yan Huang, Yagesh Bhambhani, Lyn Sonnenberg, Brenda Clark, Yuan-zhe Jin, Wei-neng Fu, Jie Zhang, Qian Yu, Xue-ting Liang, Ming Zhang. Genetic Effects on Sensorineural Hearing Loss and Evidence-based Treatment for Sensorineural Hearing Loss [J]. Chinese Medical Sciences Journal, 2015, 30(3): 179-188.

Early edition

Current issue

Archive

Specialties & Topics

Author center

Reviewer center